The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes. [electronic resource]
Producer: 20180409Description: 735-748 p. digitalISSN:- 1880-3873
- Anticholesteremic Agents -- therapeutic use
- Biomarkers -- blood
- Diabetes Mellitus, Type 2 -- blood
- Drug Therapy, Combination
- Ezetimibe -- therapeutic use
- Female
- Fenofibrate -- therapeutic use
- Follow-Up Studies
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypolipidemic Agents -- therapeutic use
- Lipids -- blood
- Male
- Middle Aged
- Prognosis
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.